NCT05155085 · Interventional trial
A Study to Assess Subcutaneous Lirentelimab (AK002) in Atopic Dermatitis
Overall registry status Terminated
Phase 2
Conditions Atopic Dermatitis
Delaware Valley sites
- Allakos Investigational Site 218-010 · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory